Chios mastic improves blood pressure haemodynamics in patients with arterial hypertension: Implications for regulation of proteostatic pathways

Abstract

Get full access to this article

View all access options for this article.

References

Triantafyllou

Chaviaras

Sergentanis

et al.

Chios mastic gum modulates serum biochemical parameters in a human population. J Ethnopharmacol 2007; 111: 43–49.

Dedoussis

Kaliora

Psarras

et al.

Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression. Atherosclerosis 2004; 174: 293–303.

Dimas

Pantazis

Ramanujam

. Review: Chios mastic gum: a plant-produced resin exhibiting numerous diverse pharmaceutical and biomedical properties. In Vivo 2012; 26: 777–785.

Georgiopoulos

Stamatelopoulos

Lambrinoudaki

et al.

Prolactin and preclinical atherosclerosis in menopausal women with cardiovascular risk factors. Hypertension 2009; 54: 98–105.

Williams

Lacy

Thom

et al.

Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213–1225.

Avanzini

Marzona

Baviera

et al.

Improving cardiovascular prevention in general practice: results of a comprehensive personalized strategy in subjects at high risk. Eur J Prev Cardiol 2016; 23: 947–955.

Pini

Cavallini

Palmieri

et al.

Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008; 51: 2432–2439.

Altman

Bland

. Statistics notes. Treatment allocation in controlled trials: why randomise? BMJ 1999; 318: 1209–1209.

Jansen

Dalmeijer

Visseren

et al.

Adult derived genetic blood pressure scores and blood pressure measured in different body postures in young children. Eur J Prev Cardiol 2017; 24: 320–327.

10.

Wang

et al.

Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension. Hypertension 2009; 54: 625–632.